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Abstract
Background: Fecal Incontinence (FI) can seriously affect quality of life. The treatment of fecal incontinence starts
conservatively but in case of failure, different surgical approaches may be proposed to the patient. Recently several
not invasive approaches have been developed. One of these is the radiofrequency (RF) energy application to the
internal anal sphincter.
Case presentation: We report a rare case of an anal abscess related to a SECCA procedure in a 66-year-old woman
affected by gas and FI for twenty years.
Conclusions: The complications post-SECCA procedure reported in literature are generally not serious and often
self-limited, such as bleeding or anal pain. This is a case of an anal abscess.
We suggest that this finding could consolidate the importance of administering antibiotic therapy to patients and
to run a full course of at least 6 days rather than a short-term (24 h) therapy, with the aim to minimize the
incidence of this complication.
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Background
Fecal incontinence (FI) is usually defined as the uninten-
tional passing of stool in an inappropriate place or time
more than two times a month. FI represents a worldwide
problem affecting up to 12% of the general population and
although is not considered a life-threatening disorder, it can
seriously impair the quality of life of patients, frequently
resulting in handicap [1, 2]. This disease is often
under-diagnosed, under-reported and poorly managed. FI
morbidity increases with age and is frequently observed up
to 45% in over 70 years old population [3]. Treatment of FI
is usually stratified from conservative to surgical treatments.
The first approach starts with a fiber-enriched diet, physio-
therapy of the pelvic floor and medication inducing consti-
pation. When unsuccessful, a sphincter repair can be
offered to patients presenting an anal sphincter defect. So
far, the available surgical procedures include dynamic graci-
loplasty [4], sacral neuromodulation [5] and artificial bowel
sphincter [6]. However, these treatments are often not com-
pletely satisfactory, carry considerable side effects and de-
mand specific expertise. Moreover, data obtained in
randomized trials are currently limited, and reliable guide-
lines for the optimal treatment of FI are still lacking.
Current practice guidelines for FI treatment are mainly
based on expert opinions, clinical experience, and case
studies [7]. Recently, less invasive approaches for the treat-
ment of FI have been developed. One of these is the appli-
cation of RF energy to the internal anal sphincter, the
SECCA procedure. For the last two decades RF energy has
been already used to treat gastroesophageal reflux disease,
prostatic hypertrophy, sleep apnea syndrome, ablation of
hepatic tumors, spinal lesions, renal tumors, and joint cap-
sule instability [8].
The SECCA procedure works on the principle that,
once applied on the affected area, it induces modifica-
tions of the internal anal sphincter structure that should
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cause collagen deposition and fibrosis with the potential
effect of tightening of the affected area. In particular, RF
energy results in vibration of water molecules and subse-
quent frictional heating when delivered to a tissue in the
frequency range of 200 kHz to 3.3 MHz [9–11]. Applica-
tion of SECCA procedure in an animal model appeared
to induce morphological changes in the internal and ex-
ternal anal sphincters leading to an anatomical state
reminiscent of normal sphincter structure [12]. Thus,
the SECCA procedure provides the release of
temperature/impedance controlled RF energy to the
sphincteric complex of the anal canal. In particular, the
application of RF involves the anal canal up to 2.5 cm
from the dentate line. The SECCA handpiece is an ano-
scopic device with four nickel-titanium curved needle
electrodes (22 gauge, 6 mm in length) that are deployed
through the mucosa of the anal canal into the internal
anal sphincter muscle. The device is rotated four times
of 90° in order to treat all the surface of the anal canal
[8]. Major contraindications for the SECCA treatment
are the anal Crohn disease [13, 14] and distal ulcerative
colitis, as well as previous in loco radiotherapy (RXT).
While bowel inflammatory diseases are contraindicated
for local inflammatory status, RXT is contraindicated for
the alterations induced in the tissue architecture of the
anal canal.
Fig. 1 Transrectal endoscopic ultrasonography (TRUS). TRUS examination shows external anal sphincter echo structural normal. Internal anal
sphincter without interruption of continuity, but of reduced thickness, about 1.3 mm measured at about 9 o’clock and 3 in correspondence of
the middle part of the anal canal
Fig. 2 Abdominal CT scan. CT scan shows a small perianal lesion (32x30x28mm approximately) in the right posterior-lateral wall with hyperemic
wall and partial gas content, probably an abscess (arrows). No free fluid in the pelvis
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Case presentation
A 66 year-old woman presented with gas and FI for
twenty years. She has one daughter, born in 1970 by
cesarean section after a long labor without pelvic
lesions or lacerations. She takes the following home
therapy:
Telmisartan 40 mg, 1 tablet at 12 h and 1 tablet at 20 h;
Levotiroxine 75 mcg, 1 tablet at 8 h;
Bromazepam 1,5 mg, 1 tablet at 8 h and 1 tablet at 20 h;
Clomipramine 10 mg, 1 tablet at 8 h;
Nebivol 5 mg, 1 tablet at 8 h.
She refers FI of liquid or solid stool and gas incon-
tinence two-three times per day, which had a marked
negative impact on her social life. She is suffering
from anxiety-depressive syndrome that worsened be-
cause of incontinence. She has changed her lifestyle,
her behavior and she is very embarrassed of her
incontinence.
Physical examination: nothing to report.
Rectal exploration: anal sphincter hypotonia.
Anorectal manometry was performed with detection of:
 Low median basal pressure: 20 mmHg (normal
range 40–60 mmHg),
 The lower limit of normal pressure after maximal
voluntary contraction: 93 mmHg,
 Duration of maximal voluntary contraction 15 s
(normally more than 1 min),
 Sensitivity threshold to 30 ml (normally 40–60 ml),
 Threshold of subjective reflection to 40 ml (normal
value 50–70 ml),
 Normal threshold of the inhibitory objective reflex:
40 ml (normal value 30–50 ml) (Fig. 1).
She did not perform any medical therapy for incontin-
ence but she has performed 3 cycles of rehabilitation
with anorectal biofeedback with poor benefit.
We proposed to the patient to undergo SECCA procedure.
Lithotomy position, general anesthesia was per-
formed. A dose of 500 mg of metronidazole was admin-
istered intravenously to induction of anesthesia. Then,
20 applications of RF through the 4 nickel needles of
the device were performed from the dentate line and
proceeding cranially every 5 mm to 2.5 cm total. The
same procedure was performed on the 4 quadrants of
Fig. 3 Transrectal endoscopic ultrasonography (TRUS). TRUS was performed to assess the extent of the abscess. TRUS shows normal endoscopic
appearance of the rectal mucosa. Internal anal sphincter appears seamless continuity but with a thickness of about 2.2 mm. It was confirmed, in
the right posterior-lateral area, the presence of an abscess 30 × 15 mm hypoechoic with hyperechoic images suggesting gas content
Fig. 4 Surgical removal of the abscess. Opening and deroofing with curettage of the fundus treated the abscess
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the internal anal sphincter, including the recto-vaginal
wall (which is often the thinnest area and for this rea-
son not always surgically treatable). The entire proced-
ure lasted 40 min.
The day after surgery she was discharged in good health.
After 10 days she presented intermittent hyperpyrexia, leak
of purulent material through the anus and anal pain. We
performed general physical and proctologic examination
with anoscope and found evidence of abscess of the right
posterior-lateral anal wall at 2 cm from the anal verge. We
have sent the purulent material for bacterial culture and
antibiogram: “Escherichia coli multi resistant”. The patient
has performed blood tests without indices of inflammation
replaying (Figs. 2 and 3). The authors administered anti-
biotic therapy with metronidazole and ciprofloxacin with-
out satisfactory improvement of the symptoms.
Surgery has been organized to remove the abscess
after 20 days from SECCA procedure.
The patient was in lithotomy position. Metronidazole
500 mg was administered intravenously. The authors ex-
plored the anal canal finding about 2 cm from the anal
verge, a recess of about 2–3 cm in diameter, undermined
for about 1 cm in cranial direction. Opening and deroofing
with curettage of the fundus treated the abscess (Fig. 4).
The day after surgery she was discharged in good
health. Four days after the procedure, the patient was in
good conditions. At 6 months follow up the patient was
in good health and during the anal exploration it was
possible to feel a rectal depression in the wall with a
smooth consistence. In spite of the complication and
subsequent surgical treatment, the procedure has been
able to ameliorate the patient incontinence.
Discussion and conclusion
Among the complications post-SECCA procedure, the
finding of an anal abscess is rarely described in the lit-
erature [8]. Antibiotic therapy was not sufficient to treat
the abscess but it was necessary a surgical treatment to
cure this complication.
This case seems to consolidate the importance of ad-
ministering antibiotic therapy to patients treated with
SECCA procedure. We propose to run a full course (at
least 6 days) rather than a short induction therapy, with
the aim to minimize the incidence of complications.
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